Housecall Pro Integrates with AI Mode in Google Search to Turn Home Service Searches into Booked Jobs
Pitches and Keynote Speakers Are Confirmed for Blue Magic Netherlands on November 17
The 34th Hong Kong International Optical Fair opens today
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Approved in Singapore, Filling Gap in Vitiligo Treatment
Payment Cards Group (A3A PayTech) Joins HKMA’s Agentic Finance Expert Group
SOUTH SAN FRANCISCO, Calif., June 06, 2022 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…
OV329 demonstrated robust anti-seizure activity in multiple preclinical seizure and epilepsy models, including treatment-resistant seizures…
Exploratory long-term OS analyses of TIVO-3 continue to trend in favor of tivozanib, patients with…
– Data from the Parker Institute for Cancer Immunotherapy and Cancer Research Institute multi-center Phase…
Inclacumab is a novel P-selectin inhibitor currently in Phase 3 clinical trials to reduce vaso-occlusive…
Trial will be the first clinical study of Allocetra™ in patients with cancer, following encouraging…
— Presentation at ASCO features updated results from Phase 2 ACCURACY study — — AL101…
GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 06, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC),…
BOSTON and LONDON, June 06, 2022 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a…
Presentations on the MT-6402 (PD-L1) and MT-5111(HER2) Phase I dose escalation programs demonstrate unique biology,…
SOUTH SAN FRANCISCO, Calif., June 06, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
CAMBRIDGE, Mass. and NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Jefferies Healthcare Conference European Hematology Association Congress, EHA-2022 BIO International Convention LSX World Congress MADRID,…
OREM, Utah, June 06, 2022 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a provider…
HALIFAX, Nova Scotia, June 06, 2022 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR)…
Aria Study did not achieve statistical significance on the primary endpoint Strategic realignment to focus…
Trial will evaluate AB-729, an RNAi therapy in combination with VTP-300, an immunotherapeutic, and NA…
PHILADELPHIA, June 06, 2022 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company…
PALO ALTO, Calif., June 06, 2022 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”…
Urges Stockholders to Vote “FOR” Radius’ Highly Qualified, Independent Director Nominees – Catherine J. Friedman,…